212 related articles for article (PubMed ID: 33946020)
21. Population-based Study Determining Predictors of Cancer-Specific Mortality and Survival in Pediatric High-grade Brainstem Glioma.
Maxwell R; Luksik AS; Garzon-Muvdi T; Yang W; Huang J; Bettegowda C; Jallo GI; Terezakis SA; Groves ML
World Neurosurg; 2018 Nov; 119():e1006-e1015. PubMed ID: 30138731
[TBL] [Abstract][Full Text] [Related]
22. Pilocytic astrocytoma survival in adults: analysis of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.
Johnson DR; Brown PD; Galanis E; Hammack JE
J Neurooncol; 2012 May; 108(1):187-93. PubMed ID: 22367412
[TBL] [Abstract][Full Text] [Related]
23. Characteristics and prognostic factors of age-stratified high-grade intracranial glioma patients: A population-based analysis.
Sun Y; Xiong ZY; Yan PF; Jiang LL; Nie CS; Wang X
Bosn J Basic Med Sci; 2019 Nov; 19(4):375-383. PubMed ID: 31202257
[TBL] [Abstract][Full Text] [Related]
24. Survival of Ventricular and Periventricular High-Grade Gliomas: A Surveillance, Epidemiology, and End Results Program-Based Study.
Yang W; Xu T; Garzon-Muvdi T; Jiang C; Huang J; Chaichana KL
World Neurosurg; 2018 Mar; 111():e323-e334. PubMed ID: 29258929
[TBL] [Abstract][Full Text] [Related]
25. Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival.
Marinoff AE; Ma C; Guo D; Snuderl M; Wright KD; Manley PE; Al-Sayegh H; Sinai CE; Ullrich NJ; Marcus K; Haas-Kogan D; Goumnerova L; London WB; Kieran MW; Chi SN; Fangusaro J; Bandopadhayay P
J Neurooncol; 2017 Oct; 135(1):201-211. PubMed ID: 28733870
[TBL] [Abstract][Full Text] [Related]
26. Daily intake of antioxidants in relation to survival among adult patients diagnosed with malignant glioma.
DeLorenze GN; McCoy L; Tsai AL; Quesenberry CP; Rice T; Il'yasova D; Wrensch M
BMC Cancer; 2010 May; 10():215. PubMed ID: 20482871
[TBL] [Abstract][Full Text] [Related]
27. Sex disparity in childhood and young adult acute myeloid leukemia (AML) survival: Evidence from US population data.
Hossain MJ; Xie L
Cancer Epidemiol; 2015 Dec; 39(6):892-900. PubMed ID: 26520618
[TBL] [Abstract][Full Text] [Related]
28. Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients.
Lote K; Egeland T; Hager B; Stenwig B; Skullerud K; Berg-Johnsen J; Storm-Mathisen I; Hirschberg H
J Clin Oncol; 1997 Sep; 15(9):3129-40. PubMed ID: 9294476
[TBL] [Abstract][Full Text] [Related]
29. Survival and prognostic factors in children with brain tumors: long-term follow-up single center study in Poland.
Pogorzala M; Styczynski J; Wysocki M
Anticancer Res; 2014 Jan; 34(1):323-6. PubMed ID: 24403482
[TBL] [Abstract][Full Text] [Related]
30. Survival differences in childhood and young adult acute myeloid leukemia: A cross-national study using US and England data.
Xie S; Hossain MJ
Cancer Epidemiol; 2018 Jun; 54():19-24. PubMed ID: 29554538
[TBL] [Abstract][Full Text] [Related]
31. Personalizing age-specific survival prediction and risk stratification in intracranial grade II/III ependymoma.
Deng X; Zhang X; Yang L; Lu X; Fang J; Yu L; Li D; Sheng H; Yin B; Zhang N; Lin J
Cancer Med; 2020 Jan; 9(2):615-625. PubMed ID: 31793749
[TBL] [Abstract][Full Text] [Related]
32. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
33. Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013.
Khanna V; Achey RL; Ostrom QT; Block-Beach H; Kruchko C; Barnholtz-Sloan JS; de Blank PM
J Neurooncol; 2017 Dec; 135(3):433-441. PubMed ID: 28828582
[TBL] [Abstract][Full Text] [Related]
34. Outcomes and Prognostic Factors in Pediatric Oligodendroglioma: A Population-Based Study.
Goel NJ; Abdullah KG; Lang SS
Pediatr Neurosurg; 2018; 53(1):24-35. PubMed ID: 29131101
[TBL] [Abstract][Full Text] [Related]
35. Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010.
Zhang AS; Ostrom QT; Kruchko C; Rogers L; Peereboom DM; Barnholtz-Sloan JS
Neuro Oncol; 2017 May; 19(5):726-735. PubMed ID: 28039365
[TBL] [Abstract][Full Text] [Related]
36. Pediatric brain tumours at a tertiary care hospital in Karachi.
Ahmed N; Bhurgri Y; Sadiq S; Shakoor KA
Asian Pac J Cancer Prev; 2007; 8(3):399-404. PubMed ID: 18159977
[TBL] [Abstract][Full Text] [Related]
37. Socioeconomic status (SES) and childhood acute myeloid leukemia (AML) mortality risk: Analysis of SEER data.
Knoble NB; Alderfer MA; Hossain MJ
Cancer Epidemiol; 2016 Oct; 44():101-108. PubMed ID: 27543948
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
39. Treatment trends and overall survival in patients with grade II/III ependymoma: The role of tumor grade and location.
Lopez-Rivera V; Dono A; Abdelkhaleq R; Sheth SA; Chen PR; Chandra A; Ballester LY; Esquenazi Y
Clin Neurol Neurosurg; 2020 Dec; 199():106282. PubMed ID: 33045626
[TBL] [Abstract][Full Text] [Related]
40. Primary brain and other central nervous system tumors in Appalachia: regional differences in incidence, mortality, and survival.
Ostrom QT; Gittleman H; Kruchko C; Barnholtz-Sloan JS
J Neurooncol; 2019 Mar; 142(1):27-38. PubMed ID: 30543034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
